The post New HIV Research Could Signal A Nanoparticle Breakthrough Cure For The Devastating Disease first on TwistedSifter.

The clearance rates for those coinfected with HIV and hepatitis C virus (HCV) are still higher than those with HCV alone.

Gilead Sciences Inc. Chief Executive Officer Daniel O’Day said the company’s new HIV prevention drug Yeztugo should be able ...

His study showed that around 5 percent of HIV-infected children who receive antiretrovirals within the first six months of ...

The jump in cases can only be described as “explosive”, said Dr Kesaia Tuidraki. In hospitals and clinics across Fiji, ...

Recent developments in antiretroviral therapy (ART) include longer-acting therapies that don't require a daily oral pill and ...

In the Southeastern US, a pediatric-to-adult HIV care transition model shows low viral suppression despite optimal engagement ...

Once-weekly semaglutide significantly slowed epigenetic aging in adults with HIV-associated lipohypertrophy, as measured by ...

Gilead Sciences on Thursday reported flat second-quarter earnings on slightly higher revenue and raised its full-year ...